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Abstract: Haemolysin BL is an important virulence factor regarding the diarrheal type of food
poisoning caused by Bacillus cereus. However, the pathogenic importance of this three-component
enterotoxin is difficult to access, as nearly all natural B. cereus culture supernatants additionally
contain the highly cytotoxic Nhe, the second three-component toxin involved in the aetiology of
B. cereus-induced food-borne diseases. To better address the toxic properties of the Hbl complex,
a system for overexpression and purification of functional, cytotoxic, recombinant (r)Hbl components
L2, L1 and B from E. coli was established and an nheABC deletion mutant was constructed from
B. cereus reference strain F837/76. Furthermore, 35 hybridoma cell lines producing monoclonal
antibodies (mAbs) against Hbl L2, L1 and B were generated. While mAbs 1H9 and 1D8 neutralized
Hbl toxicity and thus, represent important tools for future investigations of the mode-of-action of
Hbl on the target cell surface, mAb 1D7, in contrast, even enhanced Hbl toxicity by supporting the
binding of Hbl B to the cell surface. By using the specific mAbs in Dot blots, indirect and hybrid
sandwich enzyme immuno assays (EIAs), complex formation between Hbl L1 and B, as well as L1
and L2 in solution could be shown for the first time. Surface plasmon resonance experiments with
the rHbl components confirmed these results with KD values of 4.7 × 10−7 M and 1.5 × 10−7 M,
respectively. These findings together with the newly created tools lay the foundation for the detailed
elucidation of the molecular mode-of-action of the highly complex three-component Hbl toxin.
Keywords: Bacillus cereus; complex formation; enterotoxins; haemolysin BL; monoclonal antibodies
1. Introduction
The Gram-positive, facultative anaerobe and rod-shaped bacterium Bacillus cereus has become
increasingly important as a cause of food poisoning outbreaks. It is ubiquitous in soil, sediments,
dust and plants [1]. From there, it can easily be spread to different foods. B. cereus is found in
an extraordinary variety of food, as for example in milk and dairy products, rice and pasta or spices,
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dry foods and vegetables [1–3]. Food poisoning caused by B. cereus is mostly moderate and self-limiting,
but also severe and even lethal cases have been reported [4–6].
B. cereus causes mainly two types of foodborne diseases, an emetic and a diarrheal form. The first
is characterized by nausea and vomiting and is caused by the cyclic dodecadepsipeptide cereulid,
which is produced in foods before consumption [7,8]. Three types of enterotoxins are responsible for
the diarrheal form. These are produced foremost in the intestine from viable bacteria that, most likely
as spores, survived the stomach passage [9]. These enterotoxins are the three component complexes
Hbl (haemolysin BL; [10]) and Nhe (non-haemolytic enterotoxin; [11]), and the single protein CytK
(cytotoxin K; [4]). CytK has been reported to be haemolytic, cytotoxic, necrotic and is a member of the
family of β-barrel pore forming toxins [12,13]. Only very few strains express the highly toxic CytK1
variant and are classified as Bacillus cytotoxicus [14].
The more complex Nhe and Hbl toxins consist of three components each, namely NheA, B and
C and Hbl L2, L1 and B. It has been shown that for both toxins all three components are needed for
maximum biological activity [10,15]. Intensive studies have been performed on the mode of action
of Nhe. It has been shown that NheB and C, but not NheA can bind to Vero cells. Nhe is a pore
forming toxin inducing cell lysis with an optimum molar ratio for maximum toxicity of A:B:C = 10:10:1.
Increasing ratios of NheC lead to inhibition of the toxic activity [15,16]. Moreover, a specific binding
order, i.e., NheC-B-A, is necessary for Nhe activity [17–19]. The mode-of-action of Nhe was clarified
with the help of monoclonal antibodies (mAbs), which hinder the interaction between the single Nhe
components and thus, neutralize the toxic activity [18,20]. On the other hand, these specific mAbs
were also used to detect complex formation of Nhe components in culture supernatants, such as the
interaction between NheB and C [21].
Hbl was originally purified from B. cereus strain F837/76 and a binding component (B) as
well as two lytic components (L2 and L1) were identified [22,23]. Several different ideas about
the mode of action of Hbl exist. First, it has been suggested that each component is able to bind
individually to erythrocytes and thus, that they assemble into a “membrane attack complex”, then form
a transmembrane pore and lyse the cells [24]. Osmotic protection assays showed that Hbl is a pore
forming toxin and that pores are smaller than 1.2 nm [24]. On blood agar plates, it was observed
that excess of Hbl L1 or B inhibits haemolytic activity [24,25]. Thus, a certain concentration ratio of
the Hbl components might also be required for maximum activity, but this is, in contrast to Nhe,
so far unknown. In another approach it was shown that sequential binding in the specific binding
order of Hbl B-L1-L2 leads to toxic activity in cell viability tests on Chinese hamster ovary cells [19].
As the crystal structure of Hbl B was solved, a high structural similarity to E. coli haemolysin E (HlyE;
ClyA) was observed despite low sequence homology [26]. Based on this similarity, another model was
proposed in which Hbl B alone might be able to oligomerize on the cell surface and form a pore. L2 and
L1, which are definitely required for toxic activity, might either stabilize B, induce conformational
changes to B or even enter the cell [26].
Investigating Hbl activity in natural B. cereus culture supernatants is difficult, as all known
enteropathogenic strains that bear hbl also have the nhe operon. The nhe genes can be found in
all enteropathogenic B. cereus strains, the hbl genes in about 45%–65% [27–29]. Early studies on
Hbl activity were carried out with proteins purified via anion exchange chromatography from
B. cereus culture supernatants [23,30]. These might have contained trace contaminations and the use
of recombinantly expressed and purified Hbl (rHbl) components was recommended [10]. For a long
time rHbl components could not be generated, it was even suggested that the individual components
might be toxic for E. coli [31]. Only in 2013, Sastalla and co-workers were able to overexpress B. cereus
Nhe and Hbl proteins in a Bacillus anthracis expression system [19].
The aim of this study was to create suitable and effective tools by which the complex
mode-of-action of Hbl can be investigated. First, functional rHbl components were overexpressed and
purified from E. coli in an easy, fast and secure (S1) system. Secondly, a deletion mutant from B. cereus
reference strain F837/76 was constructed lacking the nhe operon. Finally, a whole set of highly specific
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mAbs against the three Hbl components was generated. Based on these reagents, it could be shown
for the first time that Hbl components L1 and B, as well as L1 and L2 form complexes in solution.
2. Results
2.1. Generation of Functional Recombinant Hbl (rHbl) Components and a ∆nheABC Mutant
To generate functional, recombinant Hbl toxin, an approach based on the Strep-tag® purification
system (iba lifesciences) was used. rHbl L2 and B were expressed with an N-terminal, rHbl L1
with a C-terminal strep-tag. Sequences encoding putative secretion signal peptides were eliminated.
Amino acid sequences and predicted molecular weight of the new recombinant proteins are shown
in Figure 1A. The proteins were overexpressed in E. coli BL21 (DE3) and purified via affinity
chromatography. Purification was controlled in Western blots (Figure 1B). Each of the single
components was detected by a strep-specific antibody as well as by the Hbl-specific mAbs. rHbl L2
and L1 were detected at their predicted molecular weight of 48.7 and 42.4 kDa, while rHbl B appeared
slightly bigger in Western blot analyses than its predicted 40.9 kDa. For rHbl L1, a second band was
detected with the L1- but not with the strep-specific mAb, indicating partial cleavage of the tag.
A ∆nheABC mutant was constructed from B. cereus strain F837/76. The nhe operon was replaced
by a spectinomycin resistance cassette, which was confirmed by sequencing. The start and stop codon,
as well as the first 36 and the last 18 bp of the operon remained. No phenotypical differences could
be detected compared to the wild type (Figure 1C). Western blots (Figure 1D) confirmed that no Nhe
toxin was produced by the deletion strain.
To determine the toxic activity of the newly generated rHbl components and the ∆nheABC strain,
they were analysed by PI influx tests as well as by WST-1-bioassays. The rHbl components were clearly
able to induce pore formation in Vero cells when applied simultaneously (Figure 1E). Fluorescence
could be measured after approximately 25 min, while supernatant of strain F837/76, which was used
as control, caused almost immediate PI influx. Simultaneously applied rHbl components were also
able to kill Vero cells (Figure 1F), although the reciprocal titre (the dilution to get 50% viable cells after
24 h) was significantly lower than that of F837/76 supernatant (250 compared to 700). The ∆nheABC
mutant showed decelerated PI influx compared to the wild type (Figure 1E) as well as a reduced
reciprocal cytotoxicity titre (400 compared to 700; Figure 1F). Altogether, these results prove that,
in contrary to earlier claims, overexpression and purification of functional rHbl in E. coli as well as the
deletion of the nhe operon in B. cereus is indeed possible.Toxins 2017, 9, 288    4 of 19 
 
 
Figure 1. Properties of the recombinant Hbl components and the nheABC deletion strain. (A) Amino 
acid sequences of rHbl L2, L1 and B. Strep‐tags are shown in blue, linker amino acids in orange letters, 
the predicted secretion signal sequences are underlined and eliminated sequences are highlighted in 
grey.  From  these  sequences  the  molecular  weight  was  predicted  (http://web.expasy.org/ 
compute_pi/). (B) Detection of the rHbl components in Western blots. The strep‐specific StrepMAB‐
Classic was used for detection (upper blot), as well as the Hbl‐specific mAbs 8B12 (L2) [32], 1E9 (L1) 
[29] and 1B8  [29]  (lower blot).  (C) Growth of B. cereus strains F837/76 and F837/76 ∆nheABC  in LB 
medium. Medium was inoculated to an OD600 of 0.005 and growth at 37 °C was monitored for 24 h. 
(D) Western blot. NheA, B and C were detected in the supernatant of strain F837/76 using the mAbs 
1A8 [20], 2B11 [20] and 3D6 [21], respectively. These proteins were not detected in the supernatant of 
the nheABC deletion mutant. (E) Influx of PI into Vero cells, represented by increasing fluorescence 
counts.  1.5 pmol/μL  rHbl  components were  either used  separately  or mixed  in  a  1:1:1  ratio  and 
applied  in  1:40 dilution  to  the  cells,  as was  supernatant  of  F837/76  ∆nheABC. CGY medium  and 
supernatant of F837/76 were used as controls. (F) Results of a WST‐1‐bioassay (Vero cells) determining 
toxic activity of the nheABC deletion strain and the rHbl components (1.5 pmol/μL each, separately or 
mixed in a 1:1:1 ratio). CGY medium and supernatant of F837/76 were used as controls. 
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Figure 1. Properties of the recombinant Hbl components and the nheABC deletion strain. (A) Amino
acid sequences of rHbl L2, L1 and B. Strep-tags are shown in blue, linker amino acids in orange letters,
the predicted secretion signal sequences are underlined and eliminated sequences are highlighted in
grey. From these sequences the molecular weight was predicted (http://web.expasy.org/compute_pi/).
(B) Detection of the rHbl components in Western blots. Th strep-specific Str MAB-Classic was used
for detection (upp r blot), as well as the Hbl-specific mAbs 8B12 (L2) [32], 1E9 (L1) [29 and 1B8 [29]
(lower blot). (C) Growth of B. cereus strains F837/76 and F837/76 ∆nheABC in LB medium. Medium
was inoculated to an OD600 of 0.005 and growth at 37 ◦C was monitored for 24 h. (D) Western blot.
NheA, B and C were detected in the supernatant of strain F837/76 using the mAbs 1A8 [20], 2B11 [20]
and 3D6 [21], respectively. These proteins were not detected in the supernatant of the nheABC deletion
mutant. (E) Influx of PI into Vero cells, represented by increasing fluorescence counts. 1.5 pmol/µL
rHbl components were either used separately or mixed in a 1:1:1 ratio and applied in 1:40 dilution to
the cells, as was supernatant of F837/76 ∆nheABC. CGY medium and supernatant of F837/76 were
used as controls. (F) Results of a WST-1-bioassay (Vero cells) determining toxic activity of the nheABC
deletion strain and the rHbl components (1.5 pmol/µL each, separately or mixed in a 1:1:1 ratio).
CGY medium and supernatant of F837/76 were used as controls.
2.2. Generation of Monoclonal Antibodies (mAbs) against Hbl
Highly specific mAbs were generated in this study according to established procedures [20,32].
For immunogen preparation, strain MHI 1532 was chosen, as it showed the highest Hbl B titres
in indirect EIAs and the highest Hbl L2 titres in sandwich EIAs of all strains tested in preliminary
experiments (data not shown). The immunogen was gained by purification of the culture supernatant
via Hbl B-specific IAC with the already established Hbl B-specific mAb 1B8 [29]. Purified Hbl toxin
was used for immunization and two booster injections of mice. After cell fusion, 35 hybridoma cell
lines secreting Hbl-reactive antibodies could be identified (Table S1). The target antigens of the mAbs
were determined in indirect EIAs using rHbl components. Twenty-nine hybridoma cell lines produced
Hbl B-specific mAbs, four mAbs were cross-reactive with Hbl B and Hbl L1, and two mAbs were
specific for Hbl L2. As mice were immunized with a preparation of IAC-purified Hbl B from B. cereus
culture supernatants (see above), this finding gave a first hint that the single Hbl components form
complexes in solution.
With respect to affinity, stability and productivity of the hybridoma cell lines, 1G8 and 12D12
(Hbl B/L1), 1D8 and 1H9 (Hbl L2), and 2G4, 1D7, 1D12 and 1C12 (Hbl B) were chosen for mass
production and the respective, purified mAbs were used for further experiments.
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2.3. The Generated mAbs Show Neutralizing and Enhancing Properties towards Hbl Toxicity
To investigate the neutralizing properties of the generated mAbs against Hbl, antibodies
were applied simultaneously with culture supernatants of B. cereus strain F837/76 ∆nheABC in
WST-1-bioassays on Vero cells. The reciprocal titre of the untreated supernatant was set to 100%
and relative cytotoxicity of all tested samples was compared to that value. mAbs 1H9 and 1D8
(Hbl L2-specific) clearly reduced the toxic activity of the Hbl-containing B. cereus supernatant by
approximately 60%, while unexpectedly mAbs 1D7 (Hbl B), 1D12 (Hbl B) and 12D12 (Hbl B/L1)
enhanced it by 256, 101 and 165%, respectively (Figure 2A). Isotype controls as well as all other tested
mAbs showed no significant influence on Hbl toxicity. The three mAbs enhancing Hbl toxicity were
used in flow cytometric analyses to determine their influence on Hbl B binding to Vero cells. For that,
Vero cells were incubated for 1 h with rHbl B (6.5 pmol/mL) and then probed with Alexa Fluor®
488-labelled mAb 1G8 (Hbl B/L1-specific). These settings resulted in approximately 42% fluorescence
(FL1)-positive cells (Table 1). Co-incubation of rHbl B and mAbs 1D12 and 12D12 on Vero cells resulted
in no and only slightly enhanced number of FL1-positive cells, respectively. However, when rHbl B
was co-incubated on Vero cells with the Hbl B-reactive mAb 1D7, nearly all cells were FL1 positive
(96.37%) (Table 1 and Figure 2B). Under consecutive incubation conditions, in which Vero cells were
first incubated with rHbl B and then, after washing, with mAb 1D7, this effect was not seen. Negative
and isotype controls proved the specificity of the reaction (Table 1). Overall, it could be demonstrated
that rHbl B binds specifically to Vero cells and that Hbl B-specific mAb 1D7 enhances this binding by
a so far unknown mechanism. The variety of enhancing or neutralizing properties indirectly indicates
that the generated mAbs recognize different epitopes.Toxins 2017, 9, 288    6 of 19 
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Table 1. Flow cytometry of Vero cells treated with rHbl B. Vero cells (1 × 106) were incubated for 1 h 
with rHbl B (6.5 pmol/mL) and simultaneously with mAbs 1D7 (Hbl B‐specific), 1D12 (Hbl B‐specific) 
or 12D12 (Hbl B/L1‐specific) (ratio mAb:rHbl B = 1:1). Fluorescence was detected via Hbl B‐specific 
Alexa Fluor® 488‐labelled mAb 1G8 (FL1, fluorescence at 488 nm). 
Sample FL1‐Positive (%) 
negative controls:   
‐  0.69 ± 0.29 
1D7  0.96 ± 0.12 
1D12  0.68 ± 0.03 
12D12  0.53 ± 0.06 
rHbl B and mAbs co‐incubated:   
rHbl B  41.95 ± 6.3 
rHbl B + 1D7  96.37 ± 4.34 
rHbl B + 1D12  43.99 ± 6.42 
rHbl B + 12D12  50.81 ± 4.11 
rHbl B and mAb 1D7 consecutively:   
rHbl B, 1D7  32.76 ± 24.61 
isotype controls:   
rHbl B + IgG1  58.37 ± 7.33 
rHbl B + IgG2a  46.36 ± 1.34 
2.4. Complex Formation of rHbl Components 
The  panel  of  Hbl‐specific  mAbs  with  putative  different  epitope‐specificity  offered  the 
opportunity to investigate possible interactions between the single rHbl components. For that, Dot 
blots and enzyme immunoassays were performed. For Dot blot analyses, a dilution series (480–3.75 
pmol) of the first rHbl component was applied to a PVDF membrane, which was then incubated with 
the second rHbl component (30 pmol in PBS). For detection, a specific mAb against the second rHbl 
component was used. Hereby, specific interactions between rHbl L1 and B as well as rHbl L1 and L2, 
but not rHbl L2 and B were demonstrated, whereat the application order of the rHbl components was 
not important (Figure 3A and Figure S1). A similar composition applied in indirect EIAs confirmed 
the  specific  complex  formation  between  rHbl  L1  and  B,  and  rHbl  L1  and  L2  (Figure  3B).  These 
i re 2. I fl e ce of bs o bl toxicity. ( ) S -1- ioassay o ero cells. Supernatant of F837/76
nhe B as applied as serial dilution. b (10 µg/ ell) as added to each dilution and incubated
ith the cells for 24 h. Cytotoxicity titres were determined by addition of WST-1. The reciprocal titre of
the untreated B. cereus supernatant was set to 100%. (B) Flow cyto etry results of ero cells treated
ith r bl B. Cells were incubated for 1 h with either only buffer (black curve), Hbl B-specific mAb 1D7
(red curve), rHbl B (light green filled) or rHbl B + mAb 1D7 (dark green filled). Cell-bound rHbl B was
detected by using Alexa Fluor® 488-labelled mAb 1G8 (Hbl B-specific).
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Table 1. Flow cytometry of Vero cells treated with rHbl B. Vero cells (1 × 106) were incubated for 1 h
with rHbl B (6.5 pmol/mL) and simultaneously with mAbs 1D7 (Hbl B-specific), 1D12 (Hbl B-specific)
or 12D12 (Hbl B/L1-specific) (ratio mAb:rHbl B = 1:1). Fluorescence was detected via Hbl B-specific
Alexa Fluor® 488-labelled mAb 1G8 (FL1, fluorescence at 488 nm).
Sample FL1-Positive (%)
negative controls:
- 0.69 ± 0.29
1D7 0.96 ± 0.12
1D12 0.68 ± 0.03
12D12 0.53 ± 0.06
rHbl B and mAbs co-incubated:
rHbl B 41.95 ± 6.3
rHbl B + 1D7 96.37 ± 4.34
rHbl B + 1D12 43.99 ± 6.42
rHbl B + 12D12 50.81 ± 4.11
rHbl B and mAb 1D7 consecutively:
rHbl B, 1D7 32.76 ± 24.61
isotype controls:
rHbl B + IgG1 58.37 ± 7.33
rHbl B + IgG2a 46.36 ± 1.34
2.4. Complex Formation of rHbl Components
The panel of Hbl-specific mAbs with putative different epitope-specificity offered the opportunity
to investigate possible interactions between the single rHbl components. For that, Dot blots and
enzyme immunoassays were performed. For Dot blot analyses, a dilution series (480–3.75 pmol) of the
first rHbl component was applied to a PVDF membrane, which was then incubated with the second
rHbl component (30 pmol in PBS). For detection, a specific mAb against the second rHbl component
was used. Hereby, specific interactions between rHbl L1 and B as well as rHbl L1 and L2, but not rHbl
L2 and B were demonstrated, whereat the application order of the rHbl components was not important
(Figure 3A and Figure S1). A similar composition applied in indirect EIAs confirmed the specific
complex formation between rHbl L1 and B, and rHbl L1 and L2 (Figure 3B). These complexes could
also be detected in a different approach where rHbl L1 and B, and rHbl L1 and L2 were pre-incubated
for 30 min and subsequently detected in highly specific sandwich EIAs (Figure 4A). This variant also
allowed the comparison of different ratios of the single rHbl components (Figure 4B). Hbl complexes
were detected in all tested variants. In the 1E9-1B8-sandwich EIA, rHbl L1 + B complexes were less
well detected with excess of B. Excess of L1 had little influence on complex detection compared to
the 1:1 ratio. In the 1G8 (Hbl HblB/L1-1H9 Hbl L2)-sandwich EIA, rHbl L1+L2 complexes were less
well detected with excess of L2. A ratio of L1:L2 of 5:1 resulted in the highest absorption values,
while further excess (10:1) showed no difference to the 1:1 control. Complex formation between rHbl
L2 and B could be detected neither in indirect nor in sandwich EIAs (data not shown).
Finally, complex formation between rHbl L1 and L2 as well as rHbl L1 and B was confirmed via
surface plasmon resonance (SPR). For that, rHbl L1 was immobilized, and rising concentrations (from
7.8 nM to 2 µM) of rHbl L2 and B were added. KD values of 1.5 × 10−7 M and 4.7 × 10−7 M were
determined, respectively (Figure 5A,B). When rHbl L2 was coupled to the sensor chip, only interaction
with rHbl L1 was detected, not with B (data not shown). Interestingly, switching rHbl B and L2
(B coupled and L2 used as ligand), resulted in specific interaction of the two proteins, with a, compared
to the results obtained in Figure 5A,B, relative low KD value of 3.4 × 10−6 M (Figure 5C).
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Figure 3. Detection of rHbl complex formation. (A) Dot blot. PVDF membranes were coated with
rising concentrations (3.75–480 pmol) of different rHbl components. After blocking, the membrane was
incubated in PBS with the second component (30 pmol). Proteins were detected using the Hbl B-specific
mAb 1B8 [29] and the Hbl L2-specific mAb 1H9 (this study). Inversion of the protein order showed
similar results and negative controls confirmed the specificity of the reaction (see Figure S1). (B) Indirect
EIA. The first rHbl component was applied as serial dilution to a microtiter plate. After washing,
the second rHbl component was applied in constant concentration (60 pmol/mL). After blocking,
Hbl B-specific mAb 1B8 [29] and Hbl L2-specific mAb 1H9 (this study) were applied, respectively,
followed by rabbit-anti-mouse-HRP conjugate for detection. Details on the non-linear regression are
shown in Table S2.Toxins 2017, 9, 288    8 of 19 
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Figure 5. SPR measurement of the rHbl components. On the left side, a representative sensogram is 
depicted.  Right  panels  show  binding  curves  fitted  to  a  one‐site‐binding model with  calculated 
equilibrium dissociation rates (KD) and errors as standard deviations from three or four independent 
experiments. (A) rHbl L1 immobilized on a sensor chip. Concentration series (7.8 nM ‐ yellow, 15.6 
nM ‐ magenta, 31.2 nM ‐ red, 62.5 nM ‐ cyan, 125 nM ‐ green, 250 nM – blue and gray, 500 nM – dark 
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Figure 4. Detection of rHbl complex formation via sandwich EIAs. (A) Microtiter plates were coated
with mAbs 1E9 (Hbl L1) [29] and 1G8 (Hbl B/L1) (this study), respectively. rHbl components were
pre-mixed (each 1.5 pmol/µL in an 1:1 ratio), incubated for 30 min at RT and, after blocking, applied
as serial dilution. After washing, the specific conjugates 1B8-HRP (Hbl B) [29] and 1H9-HRP (Hbl L2)
(this study) were used for detection. (B) In an analogous approach, rHbl components were pre-mixed
in different concentration ratios (each 1.5 pmol/µL, ratios 1:1, 5:1, 10:1, 1:5 and 1:10). Details on the
non-linear regression are shown in Table S2.
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1 µM—gray, 2 µM—dark yellow and 4 µM—dark magenta) of rHbl L2 were applied. RU: response
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2.5. Complex Formation in Natural B. cereus Culture Supernatants
To detect complex formation of Hbl components in natural B. cereus supernatants, sandwich EIAs
were performed with serial dilutions of F837/76 supernatant (analogously to Figure 4). Hbl L1-B
complexes could be detected (Figure 6A). As only very weak signals were detected in the Hbl
L1-L2-specific sandwich EIA (Figure 6B), the specific mAbs were switched (anti-L2 1H9 as capture
and anti-L1 1G8 as detection antibody) and clearer signals were determined (Figure 6C). Altogether,
with the complex sandwich EIAs, effective tools were developed to prove Hbl complex formation not
only within recombinant Hbl components, but also in natural B. cereus culture supernatants.Toxins 2017, 9, 288    10 of 19 
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Figure 6. Hbl complex formation in natural B. cereus supernatants. I ll tests, supern tant of strain
F837/76 was applied as serial dilution. Sandwich EIA spe ific for Hbl L1-B complexes, using
mAb 1E9 (Hbl L1) an the 1B8- j gate (Hbl B) [29]. (B) Sandwich EIA specific for Hbl 1-L2
complexes, using mAb 1G8 (Hbl L1) and the 1H9-HRP conjugate ( bl L2) (this study). (C) Due to weak
results in Figure 6B, the capture and detection mAbs for Hbl L1 (1G8) and L2 (1H9) were switched.
Details on the non-linear regression are shown in Table S2.
In an independent approach, MHI 1532 supernatant was purified via IAC using the Hbl B-specific
mAb 1B8 [29] equivalently to the generation of the immunogen. Single fractions were collected and
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tested in sandwich EIAs. Results of three independent approaches are summarized in Table 2. Hbl B
and L1 bound with high capacity to the IAC column, less than 5% of these toxin components were
detected in sample flow-through and wash fraction. The detectable proportion of Hbl B and L1 in the
elution fraction averaged at 187% and 180% compared to the MHI 1532 supernatant. The recovery
rate of Hbl L2 in the elution fraction averaged at only 29%, while 51% were detected in the sample
flow-through and 20% in the wash fraction. A sandwich EIA against the toxin component NheB
was performed to exclude unspecific binding of toxin components to the immunosorbent. Indeed,
97% of NheB were detected in the sample flow-through. As a control, the identical experiment was
performed using the Hbl L2-specific mAb 1H9 coupled to the CnBr-activated sepharose 4B matrix.
Ninety percent of Hbl L2 were retrieved in the elution fraction, whereas only 2% and 1% of Hbl L1 and
B were detected, respectively (Table 2). Corresponding Western blot analyses confirmed the foregoing
results (Figure 7). Altogether, Hbl B as well as L2 and L1 could be detected in the elution fraction of
the Hbl B-specific 1B8-IAC and prove the pronounced complex formation between the single Hbl
components in natural supernatants.
Table 2. Proportion of Hbl components L2, L1 and B in sample flow-through, wash and elution
fraction after IAC purification of B. cereus MHI 1532 supernatant. Hbl B-specific mAb 1B8 [29]
and Hbl L2-specific mAb 1H9 (this study) were used for IAC. Hbl components were determined
in sandwich EIAs: Hbl L2: mAbs 1A12 [32]/1H9-HRP (this study); Hbl L1: mAbs 1E9 [29]/1G8-HRP
(this study); Hbl B: mAbs 1D12 (this study)/1B8-HRP [29]. NheB was also measured as a control (mAbs
2B11/1E11-HRP) [20]. EIA titres were multiplied with the respective sample volume resulting in units.
The respective units determined in MHI 1532 supernatant were set to 100%.
Hbl B-Specific IAC (1B8)
Sample Flow-Through Wash Fraction Elution Fraction
Hbl L2 51% 20% 29%
Hbl L1 <5% <5% 180%
Hbl B <5% <5% 187%
NheB 97% - 3%
Hbl L2-Specific IAC (1H9)
Sample Flow-Through Wash Fraction Elution Fraction
Hbl L2 9% 1% 90%
Hbl L1 55% 4.5% 2%
Hbl B 110% 10% 1%
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supernatant of  strain MHI 1532; 2,  sample  flow‐through; 3, wash  fraction; and 4, elution  fraction. 
Toxin components were detected using the following mAbs: 1H9 (Hbl L2), 1E9 (Hbl L1), 1B8 (Hbl B), 
and 1E11 (NheB) ([20,33] and this study). 
3. Discussion 
With  the  construction of  an nheABC deletion mutant  and  the  establishment of  a  system  for 
overexpression and purification of active recombinant Hbl components in E. coli, the first important 
steps towards clarification of the molecular mode‐of‐action of Hbl have been made. Earlier studies 
had  been  laborious  and  not  fully  conclusive,  as  the  second  three‐component  enterotoxin Nhe  is 
always present in crude B. cereus culture supernatants [28,29]. Furthermore, Hbl was purified in these 
early  studies  via  anion  exchange  chromatography,  including  the  possibility  that  the  resulting 
preparations might have contained trace contaminations of Nhe [10,23,30]. As Nhe dominates toxicity 
studies, another approach  to assess  the peculiar Hbl activity was  to remove NheB via subtractive 
immunoaffinity  chromatography  (IAC) and attribute  the  remaining  toxic  activity  to Hbl  [33]. By 
using rHbl components in the present study, no other B. cereus toxin is involved and the single Hbl 
components can be applied in defined concentrations and proportions. The three rHbl components 
produced in E. coli are functionally active and cytotoxic, but it must be admitted that cytotoxic activity 
is reduced compared to natural Hbl appearing in B. cereus culture supernatants (refer to Figure 1C,D).   
Based on these reactive proteins and a broad range of Hbl‐specific mAbs, complex formation 
between  the  single Hbl  components  could  be  detected  for  the  first  time. Via Dot  blots,  hybrid 
sandwich EIAs and  immunoaffinity  chromatography, Hbl L1‐B and Hbl L1‐L2  complex  formation 
could  be  shown  both  for  the  recombinant Hbl  proteins  as well  as  in  natural  B.  cereus  culture 
supernatants (refer to Figures 3, 4 and 6). Particularly, the L1 and B components seem to be highly 
complexed. The only,  comparably weak  interaction between Hbl B  and L2 was observed  in SPR 
measurements, when rHbl B was immobilized and high concentrations of rHbl L2 were added (refer 
to Figure 5C). Apart from that, SPR measurements confirmed the results obtained in hybrid sandwich 
Figure 7. Western blot analyses of Hbl B-specific IAC fractions of MHI 1532 supernatant: 1, supernatant
of strain MHI 1532; 2, sample flow-through; 3, wash fraction; and 4, elution fraction. Toxin components
were detected using the following mAbs: 1H9 (Hbl L2), 1E9 (Hbl L1), 1B8 (Hbl B), and 1E11
(NheB) ([20,33] and this study).
3. Discussion
With the construction of an nheABC deletion mutant and the establishment of a system for
overexpression and purification of active recombinant Hbl components in E. coli, the first important
steps towards clarification of the molecular mode-of-action of Hbl have been made. Earlier studies
had been laborious and not fully conclusive, as the second three-component enterotoxin Nhe is
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always present in crude B. cereus culture supernatants [28,29]. Furthermore, Hbl was purified in
these early studies via anion exchange chromatography, including the possibility that the resulting
preparations might have contained trace contaminations of Nhe [10,23,30]. As Nhe dominates toxicity
studies, another approach to assess the peculiar Hbl activity was to remove NheB via subtractive
immunoaffinity chromatography (IAC) and attribute the remaining toxic activity to Hbl [33]. By using
rHbl components in the present study, no other B. cereus toxin is involved and the single Hbl
components can be applied in defined concentrations and proportions. The three rHbl components
produced in E. coli are functionally active and cytotoxic, but it must be admitted that cytotoxic activity
is reduced compared to natural Hbl appearing in B. cereus culture supernatants (refer to Figure 1C,D).
Based on these reactive proteins and a broad range of Hbl-specific mAbs, complex formation
between the single Hbl components could be detected for the first time. Via Dot blots, hybrid sandwich
EIAs and immunoaffinity chromatography, Hbl L1-B and Hbl L1-L2 complex formation could be
shown both for the recombinant Hbl proteins as well as in natural B. cereus culture supernatants (refer
to Figures 3, 4 and 6). Particularly, the L1 and B components seem to be highly complexed. The only,
comparably weak interaction between Hbl B and L2 was observed in SPR measurements, when rHbl B
was immobilized and high concentrations of rHbl L2 were added (refer to Figure 5C). Apart from that,
SPR measurements confirmed the results obtained in hybrid sandwich EIAs, indicating that there is
an interaction and complex formation between Hbl L1 and L2 as well as L1 and B. This Hbl complex
formation also explains why all three Hbl components were detected in the elution fraction of Hbl
B-specific IAC from strain MHI 1532 (Table 2 and Figure 7), which was initially used for immunogen
preparation, and why mAbs specific for all three Hbl components (Table S1) were generated. Thus,
it can be postulated that in natural B. cereus culture supernatants Hbl B is to a large extent bound in
complexes. Further on, these complexes are characterized by KD values of 4.7 × 10−7 M (L1-B) and
3.4 × 10−6 M (B-L2) (Figure 5). These are relatively low constants compared to the situation found
for the NheB-C complexes, for which a value of 4.8 × 10−10 M was found [34]. This might be the
reason why single Hbl components were obtained from B. cereus culture supernatants with the applied
classical chromatographic approach in the early studies [23,30].
According to sequence homologies between the two three-component enterotoxin complexes of
B. cereus, Hbl L2 correlates with NheA, Hbl L1 with NheB and Hbl B with NheC [31,35]. Thus, the Hbl
L1-B complexes found in this study would correspond to NheB–NheC complexes, which have already
been well-described. It was shown that a defined level of NheB–NheC complexes as well as a sufficient
amount of free NheB is necessary for efficient cell binding and toxicity [21,34]. Based on these data,
a detailed model on the mode-of-action of Nhe could be developed [36]. Assuming that Hbl L1 is
equivalent to NheB and Hbl B to NheC, it can be speculated that the Hbl L1-B complexes alone might
be able to bind to the target cells and form a kind of “pro-pore” [34]. Analogously to NheA, Hbl L2
would be the third component which, presumably after undergoing conformational changes, binds to
the complex and completes the pore. However, the comparably low KD values of the complexes found
in this study, as well as the proposed binding order of the single components B-L1-L2 [19] oppose
this theory.
Interestingly, in our study some of the newly generated mAbs against Hbl B enhanced Hbl
toxicity towards Vero cells (refer to Figure 2A). By using purified rHbl B and flow cytometry analyses,
an increased binding of Hbl B to Vero cells in the presence of the Hbl B-specific mAb 1D7 was found
(Figure 2B and Table 1). Various studies describe enhancing effects of virus-specific mAbs, known
as antibody-dependent-enhancement (ADE) [37,38]. ADE has been described for Dengue fever [39],
HIV [40], Feline Infectious Peritonitis [41] and Ebola [42]. In 2004, ADE was first observed regarding
the lethal toxin of B. anthracis [43]. The authors postulated stabilization of PA (protective antigen)
binding to the cell surface via interaction of mAbs with macrophage Fcγ receptors. In contrast to
this, involvement of Fc receptors can be excluded in our study, as they do not occur on the surface of
Vero cells. Thus, the reason for the increased rHbl B binding remains unclear. One can speculate that
through the two binding sites of the mAb, an antibody-mediated cross-linking of rHbl B is induced,
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which might promote the binding of rHbl B to the cell surface. It is further possible that binding of the
mAb results in a change of the tertiary structure of rHbl B enabling a better binding to the target cells.
Besides these toxicity-enhancing mAbs, also mAbs with neutralizing properties were also found.
This is particularly true for the mAbs reactive with Hbl L2 (refer to Table S1 and Figure 2A). However,
these mAbs neutralize Hbl toxicity only by approximately 60%, in contrast to an earlier study,
in which an NheB-specific mAb (1E11) was generated that neutralizes Nhe-dependent toxicity almost
completely [20]. The partial neutralization of Hbl L2-specific 1H9 and 1D8 indicates that both mAbs
interact with regions of the toxin which are important, but not mandatory for toxic activity. Further
studies are necessary to determine whether these mAbs hinder the proposed conformational change of
the Hbl components during pore formation [26] or the putative attachment of Hbl L2 to cell-bound
Hbl B/L1. It might also be possible that the mAbs are not able to access Hbl L2, as it is partially bound
in complexes with the other components, as shown in this study.
The demonstration of Hbl complex formation in the current study is a first step to characterize
its mode-of-action in detail. Further studies are in progress to elucidate the epitope specificity of
the mAbs to get new insights into the interaction of the single components. Cell culture studies will
follow to investigate the impact of complex formation on the functionality and toxic activity of Hbl.
Thus it can be elucidated if the complexes either support or hinder pore formation and if—next to
Nhe—another example can be found for the so far unique, permeable “pro-pores”, or if Hbl conceals
a different mechanism of hetero-oligomerization leading to pore formation.
4. Materials and Methods
4.1. Ethics Statement
Immunizations of mice for generating monoclonal antibodies were conducted in compliance with
the German Law for Protection of Animals. Study permission was obtained by the Government of
Upper Bavaria (permit number 55.2-1-54-2532.6-2-12).
4.2. Cell Lines and Culture Conditions
Vero cells were obtained from ECACC (European Collection of Cell Cultures) and cultured in
80 cm2 culture flasks in a humidified incubator at 37 ◦C and 7% CO2 in medium recommended by
the supplier.
4.3. Bacterial Strains and Culture Conditions
In this study, the B. cereus strains F837/76 (DSM 4222), B4ac (DSM 4384), MHI 1532 (producing
high amounts of Hbl toxin) and F837/76 ∆nheABC (producing Hbl, but no Nhe toxin) were used.
For collection of toxin-rich supernatants, cells were grown in CGY medium with 1% glucose and
treated as previously described [33]. Recombinant Hbl proteins were overexpressed in the E. coli strain
BL21 (DE3), which was grown in LB medium containing 100 µg/mL ampicillin.
4.4. Construction of the nheABC Deletion Mutant
The nheABC deletion mutant was constructed as described previously with minor
modifications [44]. Briefly, for the in-frame deletion of the nheABC gene cluster, an 808 bp upstream
fragment of bcf_09260 (nheA) and an 813 bp downstream fragment of bcf_09270 (nheC) were amplified
by PCR using the primer pairs nheA-BamHI/nheA-Spc (CGGGATCCCGAGTTACTGTCGTTATACC;
CGTTAGCGTTTAAGTACATCCCCTGTAATTAAAGTCTTTTTCAC) and nheC-Spc/nheC-EcoRI
(GCGTCCTCTTGTGAAATTAGAGGATTATACAGAAAAATTACATGAAG; CGGAATTCCTCCA
TTATACGGTTCACTCG). To allow the selection of positive clones, the spectinomycin-resistance
cassette from the TOPO/Spc plasmid was amplified with oligonucleotides For_Spc-K/Rev_Spc-K
(GGATGTACTTAAACGCTAACG/CTCTAATTTCACAAGAGGACGC) and inserted between
upstream and downstream fragments using ligation-independent cloning (LIC) of PCR products [45].
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Following the next PCR using the primer pair nheA-BamHI/nheC-EcoRI and the LIC construct as
a template, the resulting fragment was cloned into the multiple cloning site of the conjugative suicide
vector pAT113 via BamHI and EcoRI, giving rise to pAT113-Spc∆nheABC. E. coli JM83/pRK24 was
transformed with pAT113-Spc∆nheABC and the resulting strain was used for transconjugal transfer
into B. cereus F837/76. Conjugation was carried out as described [46]. Transconjugants were screened
for spectinomycin resistance and erythromycin sensitivity. Gene cluster deletion and integration of the
resistance cassette resulting from a double-crossover recombination event were confirmed by PCR
and sequencing.
4.5. Cloning of Recombinant Hbl (rHbl) Components
The genes encoding Hbl L2 (hblC; bcf_15295), Hbl L1 (hblD; bcf_15290) and Hbl B (hblA;
bcf_15285) were amplified using the primer pairs HblL2-fw-KpnI (ATATGGTACCCCAAGCAGAA
ACTCAACAAGAAA) and HblL2-rev-NcoI (ATATCCATGGTCAAAATTT ATACACTTGTTCTTC),
HblL1-fw-SacII (ATATCCGCGGATGGCACAAGAAACGACCGCTCAAG) and HblL1-rev-NcoI (ATAT
CCATGGGCCTCCTGTTTAAAAGCAATATC) and HblB-fw-KpnI (ATATGGTACCCGCAAGTGA
AATTGAACAAACGAAC) and HblB-rev-NcoI (ATATCCATGGCTATTTTTGTGGAGTAACAGTT
TCTAC), respectively. Chromosomal DNA from strain F837/76 was used as template. With the
chosen primers, genes were amplified lacking the sequences for the N-terminal signal peptides for
secretion [47,48]. hblD was cloned into pASK-IBA3plus (iba lifesciences), adding a C-terminal strep-tag
to the recombinant Hbl L1 protein. hblC and hblA were cloned into pASK-IBA5plus (iba lifesciences),
resulting in addition of N-terminal strep-tags. Sequencing was performed using the primers
pASK-IBA-seq-fw (CACTCCCTATCAGTGATAG) and pASK-IBA-seq-rev (GCACAATGTGCGCCAT).
4.6. Overexpression of rHbl Components
For overexpression of the rHbl components the E. coli strain BL21 (DE3) was used. Fifty millimetres
LB medium with 100 µg/mL ampicillin were inoculated to an OD600 of 0.15. Cells were grown at 37 ◦C
to an OD600 of 0.8–0.9. After overexpression was induced by adding 1 µg/mL doxycycline, cells were
grown for further four hours and then harvested by centrifugation.
4.7. Purification of rHbl Components
The E. coli cell pellet was dissolved in 15 mL resuspension buffer (100 mM Tris, 500 mM
NaCl, 1 mM EDTA, pH 8) containing protease inhibitor complete (Roche) and 100 µg/mL lysozyme.
Cells were subsequently disrupted in an ultrasonic bath for 2× 15 min on ice. Cell debris was removed
by centrifugation for 30 min at 14,000× g and 4 ◦C. The remaining cell extract was filtered through
a 0.2 nm filter. All strep-tagged Hbl components were purified via a 0.5 mL Strep-Tactin®-Sepharose®
matrix (iba lifesciences) in a Poly-Prep chromatography column (Biorad) according to the protocol
provided by the supplier. Proteins were eluted in buffer containing 100 mM Tris, 500 mM NaCl, 1 mM
EDTA and 2.5 mM D-desthiobiotin, pH 8. Protein concentrations were determined after SDS-PAGE by
staining with Sypro Ruby in comparison to a BSA concentration standard.
4.8. Production of Monoclonal Antibodies (mAbs)
For the preparation of the immunogen, toxin was purified via immunoaffinity chromatography
(IAC) from a total of 300 mL supernatant of B. cereus strain MHI 1532 grown in CGY medium.
For this purpose, the previously established Hbl B-specific mAb 1B8 (10 mg) [29] was coupled to 1 g
CNBr-activated sepharose 4B. The column was washed with 20 mL PBS before the toxin-containing
culture supernatant was applied. After a washing step with 20 mL PBS, the toxin was eluted by
addition of 16 mL glycine/HCl solution (pH 2.5). Subsequently, the eluate was neutralized with 1 M
Tris (pH 7.0) and dialyzed three times overnight at 4 ◦C against PBS. Five 12-week-old female mice
(BALB/c and BALB/c × [NZW × NZB]) were immunized with this preparation. Each mouse received
15 µg purified toxin (immunization and first booster injection after 9 weeks) and another 12 µg (second
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booster injection after 15 weeks) emulsified in Sigma adjuvant. Three days before cell fusion each
mouse received a final injection of 20 µg toxin diluted in 0.9% NaCl-solution. Cell fusion experiments,
establishment of hybridomas, mass production and antibody purification were performed as described
previously [20,32].
4.9. SDS-PAGE, Sypro Staining and Immunoblotting
SDS-PAGE analyses were carried out on a PhastGel gradient (10 to 15%) minigel system
(GE Healthcare, Munich, Germany). For Sypro staining, proteins were fixed on the gel for 2 × 30 min
in 50% MeOH and 7% acetic acid. The gel was then incubated with 2 mL Sypro Ruby protein stain
overnight at room temperature. After 30 min washing in 10% MeOH and 7% acetic acid and additional
washing for 10 min in H2O, fluorescence signals were detected on a Kodak imager (Eastman Kodak
Company, Rochester, NY, USA).
For immunoblotting, proteins were blotted to a PVDF-P membrane (Millipore, Billerica, MA, USA),
blocked in 3% casein-PBS and incubated with 2 µg/mL mAbs 8B12 (Hbl L2) [32], 1E9 (Hbl L1) [29], 1B8
(Hbl B) [29], 1E11 or 2B11 (NheB) [20], 1A8 (NheA) [20], 3D6 (NheC) [21], mAb 1H9 (this study), or the
strep-specific StrepMAB-Classic (iba lifesciences) for 1 h at room temperature. After 3 washing steps
in PBS with 0.1% Tween 20, a 1:2000 dilution of rabbit anti-mouse-horseradish peroxidase conjugate
(Dako) was used as secondary antibody. After three further washing steps in PBS with 0.1% Tween
20 and two in PBS, Super Signal Western Femto Maximum Sensitivity Substrate (Pierce) was applied.
Chemiluminescence signals were detected on a Kodak imager (Eastman Kodak).
4.10. Labelling of mAbs
For use as detection antibodies in the sandwich EIAs, mAbs were coupled to activated peroxidase
(HRP) according to the instructions of the manufacturer (Roche). The resulting conjugate was
stabilized with 1% BSA and StabilZyme® HRP Conjugate Stabilizer (SurModics) and conserved
with 0.01% Thimerosal.
For flow cytometric analyses, mAb 1G8 was labelled with Alexa Fluor® 488 (Thermo Scientific,
Waltham, MA, USA). For that, 2 mg 1G8 (in 1 mL PBS) were mixed with 200 µL Alexa Fluor® 488.
The mixture was stirred gently for 1 h at room temperature in the dark. To remove unbound Alexa dye,
10 mL PBS were added and the material was transferred to a Amicon® Ultra-4 centrifugal filter unit
(Millipore) and centrifuged for 20 min (3000 rpm, 4 ◦C). The labelled mAb was washed with another
10 mL PBS by repeating the centrifugation step, and afterwards resuspended in PBS. NaN3 (0.1% ) was
added for conservation and 1% BSA for stabilization.
4.11. Flow Cytometry
For flow cytometry analyses, Vero cells were adjusted to 1 × 106 cells in 1 mL EC buffer (140 mM
NaCl, 15 mM HEPES, 1 mM MgCl2, 1 mM CaCl2, 10 mM glucose pH 7.2). Then 6.5 pmol/mL rHbl B
and, if applicable, mAbs were added (ratio rHbl B:mAb = 1:1). The mixture was incubated for 1 h at
37 ◦C under moderate agitation. Then, 2 mL 1% BSA-PBS were added and cells were centrifuged for
5 min at 800 rpm. Cells were washed again in 2 mL 1% BSA-PBS. When rHbl B and mAb 1D7 were
applied successively, the incubation step at 37 ◦C and the washing step were repeated. For detection of
cell-bound rHbl B, the samples were incubated with 3 µg/mL Hbl B-specific Alexa Fluor® 488-labelled
mAb 1G8 for 1 h at 4 ◦C. After additional washing, samples were resuspended in 500 µL 1% BSA-PBS
and subsequently analysed in a FACS Calibur using the CellQuestPro software (BD Bioscience).
4.12. Enzyme Immunoassays (EIAs)
Indirect and sandwich enzyme immunoassays were performed as described before [20,28,32,49].
For detection of rHbl components, established mAbs were used (1A12 and 8B12 [32] for Hbl L2,
1E9 [29] for Hbl L1 and 1B8 [29] for Hbl B), as well as the ones newly generated in this study (Table S1).
To determine relative affinities of the newly generated mAbs, B. cereus culture supernatants and rHbl
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components were used in indirect EIAs. For that, dilution series of the antigens were applied, followed
by the cell culture supernatants (constantly 1:20 in PBS). The relative affinity corresponds with the
dilution that results in an absorbance value of 1.0. The productivity of the hybridoma cell lines was
also determined in indirect EIAs. Supernatant of B. cereus MHI 1532 was applied (constantly 1:10 in
PBS), followed by dilution series of the cell culture supernatants.
rHbl complex formation was investigated using indirect and sandwich EIAs. In the indirect
assay, the microtiter plate was coated with a serial dilution of rHbl L1 (120–0 pmol/mL) overnight.
After washing, the second rHbl component was applied in constant concentration (60 pmol/mL) for
1 h. After blocking for 30 min with 3% sodium-caseinate in PBS, HblB-specific mAb 1B8 [29] and
Hbl L2-specific mAb 1H9 (this study) (2 µg/mL in PBS) were applied, respectively. After additional
washing, rabbit-anti-mouse-HRP conjugate (1:2000 in 1% sodium-caseinate in PBS) was applied for
detection. In the sandwich assay, the microtiter plate was coated with 10 µg/mL mAbs 1E9 [29] or
1G8 (this study), both Hbl L1-specific, overnight. While the plate was blocked for 30 min with 3%
sodium-caseinate in PBS, a mixture of rHbl components (L1+B or L1+L2; 1.5 pmol/µL each, ratios 1:1,
5:1, 1:5, 10:1 or 1:10) was incubated at RT. The mixtures were applied to the microtiter plate as serial
dilution from 75 to 0 pmol/mL. After washing, a specific mAb conjugate was applied for detection
(1:2000 in 1% sodium-caseinate in PBS; 1B8-HRP [29] against Hbl B or 1H9-HRP (this study) against
Hbl L2). Analogously to the detection of the rHbl components, sandwich EIAs were used to detect Hbl
complexes in the supernatant of B. cereus strain F837/76, which was applied to the microtiter plates as
serial dilution. One-site-binding curves were applied to depict the absorption values compared to the
sample dilutions.
4.13. Dot Blot
One hundred microlitres per dot of the first purified rHbl component, diluted in PBS, were applied
to a PVDF membrane (Immobilon-P, Millipore, USA) as dilution series from 480 to 3.75 pmol.
The membrane was removed from the dotting chamber and blocked with 3% sodium-caseinate-PBS
overnight. Subsequently, the second purified rHbl component was applied (30 pmol in PBS) and
overlaid on the dots for 1 h. The membrane was washed for 3 × 10 min in PBS containing 0.1% Tween
20. After that, Hbl-specific mAbs were applied (1B8 against Hbl B [29], 1H9 against Hbl L2 (this study);
1E9 [29] and 1G8 (this study) against Hbl L1; 3 µg/mL in 3% sodium-caseinate-PBS with 0.025% Tween
20) and overlaid on the dots for 1 h. The membrane was again washed for 3× 10 min in PBS containing
0.1% Tween 20 before anti-mouse-IgG-alkaline-phosphatase-conjugate (Sigma) was applied (1:10.000
in 3% sodium-caseinate-PBS with 0.025% Tween 20) for 1 h. Again, the membrane was washed for
3 × 10 min in PBS containing 0.1% Tween 20 and for 2 × 10 min in PBS before signals were detected
using NBT/BCIP solution (Roche).
4.14. Surface Plasmon Resonance (SPR)
Binding measurements were performed on a BIACORE 3000 instrument (Biacore Inc., Piscataway,
NJ, USA). In a first experiment, rHbl L1 was coupled and rHbl L2 and B were used as ligands. For that,
L1 was diluted to a final concentration of 416 nM in 10 mM sodium acetate, pH 4.8, and chemically
immobilized (amine coupling, 560 RU bound) onto a CM5 sensor chip (Biacore Inc.). The L2 and B
protein samples were diluted in running buffer (PBS, 1 mM DTT and 0.005% Tween 20) and injected
over the sensor chip surface at 30 µL/min at 20 ◦C. The samples were injected onto the sensor chip
from the lowest to the highest concentration with injection of 250 nM ligand in duplicate within each
experiment. L2 and B protein samples were measured three and four times, respectively.
For the second experiment, rHbl B was diluted to a final concentration of 350 nM in 10 mM sodium
acetate, pH 4.0. 500 RU were coupled onto a CM5 sensor chip. rHbl L2 was diluted in the same running
buffer as above and injected over the sensor chip surface at 30 µL/min at 20 ◦C. The experiment was
repeated four times. Background subtraction was done using an unmodified sensor chip surface.
Data were analysed using BIAevaluation program (Biacore Inc.). For each measurement the equilibrium
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dissociation constant (KD) was calculated from steady-state measurement. The KDS from three or
four experiments (see above) were used to calculate mean values and standard deviations. Despite
long injection times the measurement of L1 + B did not reach full binding saturation for lower protein
concentrations. Therefore, the derived KD value is likely to be slightly underestimated.
4.15. Cytotoxicity Assays
Stock solutions (1.5 pmol/µL) of the rHbl components were used for toxicity assays on Vero
cells. They were pre-mixed in appropriate ratios and added in 1:40 dilutions to the cells. Propidium
iodide (PI) influx tests were performed as described before [33,49]. WST-1 bioassays were carried
out as previously described [20,32,49]. For neutralization assays, 10 µg/well purified mAbs were
applied constantly with a serial dilution (starting 1:20) of culture supernatant of B. cereus strain
F837/76 ∆nheABC.
Supplementary Materials: The following are available online at www.mdpi.com/2072-6651/9/9/288/s1.
Table S1: Characteristics of the established hybridoma cell lines and mAbs, Table S2: Statistics of the curves fitted
to the EIA and SPR experiments, Figure S1: Detection of Hbl complex formation via Dot blot.
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